Standard Therapy and TIPS for Moderate to High-risk Esophageal and Gastric Variceal Bleeding

NARecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Portal Hypertension
Interventions
PROCEDURE

Endoscopy+NSBBs

Endoscopic treatment+NSBBs group: After admission, carvedilol 6.25mg qd p.o. was administered to lower portal vein pressure. After one week without any adverse reactions, add the dosage to 12.5mg qd, maintained for a long time, with close monitoring of blood pressure and pulse (morning and evening monitoring) during dosing and later use, to maintain systolic blood pressure\>90mmHg and heart rate\>55bpm. Otherwise, dosage reduction or even discontinuation of medication is necessary. Endoscopic treatment adopts sequential treatment, with an interval of four weeks, until the varicose vein becomes mild or disappears.

PROCEDURE

Transjugular intrahepatic portosystemic shunt

TIPS group: All TIPS procedures are completed by a professional liver disease intervention treatment team.

Trial Locations (1)

Unknown

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

All Listed Sponsors
collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Beijing Friendship Hospital

OTHER

lead

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER